Fulcrum Therapeutics FULC
NASDAQ FULC
$3.70 +0.00 (+0.14%)
As of: Sep 30, 2026 · 1:34 PM EDT

Fulcrum Therapeutics, Inc. (FULC) Operating Income (2018 - 2026)

Updated

Fulcrum Therapeutics (FULC) recorded Operating Income of -$29.31 million in Q2 2026, compared with -$19.82 million a year earlier.

Analysis

Fulcrum Therapeutics, Inc. (FULC) Operating Income (2018 - 2026) Analysis & Trends

On a TTM basis, Fulcrum Therapeutics' Operating Income came in at -$96.05 million as of Jun 30, 2026; for FY2025, it was -$84.77 million.

  • Across earlier years, Operating Income came in at -$21.9 million in FY2024, -$110.66 million in FY2023, -$112.56 million in FY2022 and -$81.05 million in FY2021.
  • The Q2 2026 figure is the lowest quarterly Operating Income since Q1 2024.
  • Per Business Quant, the preceding three quarters came in at -$22.19 million (Q1 2026), -$22.69 million (Q4 2025) and -$21.86 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.31 Mn
Mar 31, 2026 -22.19 Mn
Dec 31, 2025 -22.69 Mn
Sep 30, 2025 -21.86 Mn
Jun 30, 2025 -19.82 Mn
Mar 31, 2025 -20.40 Mn
Dec 31, 2024 -19.43 Mn
Sep 30, 2024 -25.13 Mn
Jun 30, 2024 52.49 Mn
Mar 31, 2024 -29.83 Mn
Dec 31, 2023 -27.99 Mn
Sep 30, 2023 -27.44 Mn
Jun 30, 2023 -27.29 Mn
Mar 31, 2023 -27.94 Mn
Dec 31, 2022 -27.97 Mn
Sep 30, 2022 -24.36 Mn
Jun 30, 2022 -34.24 Mn
Mar 31, 2022 -26.00 Mn
Dec 31, 2021 -23.56 Mn
Sep 30, 2021 -20.77 Mn
API Access

Fulcrum Therapeutics, Inc. Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=FULC&period=max&api_key=YOUR_API_KEY